Viralytics' IPO

Viralytics raised a round of funding on March 09, 2009. Investors include Public.

Viralytics is focused on the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to preferentially infect and kill cancer cells.…

Articles about Viralytics' IPO: